IO Biotech | 4:持股變動聲明-高管 Zocca Mai-Britt
IO Biotech | 4:持股變動聲明-高管 Smith Devin Whittemore
IO Biotech | 4:持股變動聲明-高管 Sullivan Amy
IO Biotech | 4:持股變動聲明-高管 Burkavage Brian
IO Biotech | 4:持股變動聲明-高管 Ahmad Qasim Iftikhar
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-Avoro Capital Advisors LLC(0%),Behzad Aghazadeh(0%)
IO Biotech | SC 13D/A:超過5%持股股東披露文件(修正)-Novo Holdings A/S(11.1%)
IO Biotech | 4:持股變動聲明-股東 Novo Holdings A/S
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-BANK OF AMERICA CORPORATION(2.8%)
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)-HBM Healthcare Investments (Cayman) Ltd.(6.0%)
IO Biotech | SC 13G/A:超過5%持股股東披露文件(修正)
IO Biotech | SC 13G:超過5%持股股東披露文件-Samsara BioCapital, L.P.(5.5%),Samsara BioCapital GP, LLC(5.5%)等
IO Biotech | 4:持股變動聲明-首席會計師 Burkavage Brian
IO Biotech | 4:持股變動聲明-董事 Collins Helen Louise
IO Biotech | 3:首次持股聲明-董事 Collins Helen Louise
IO Biotech | SC 13G:超過5%持股股東披露文件-Kurma Partners(17.18%)
IO Biotech | 3:首次持股聲明-股東 Kurma Partners
IO Biotech | SC 13G:超過5%持股股東披露文件
IO Biotech | 4:持股變動聲明-董事 Hunter Heidi
IO Biotech | 3:首次持股聲明-董事 Hunter Heidi
暫無數據